Abstract
Purpose
To evaluate the outcome of Acanthamoeba keratitis with respect to the delay in diagnosis.
Methods
A retrospective review of the records of 14 patients treated for Acanthamoeba keratitis was carried out. Delay in diagnosis was correlated with risk factors, clinical presentation, method of diagnosis, final visual acuity and need for penetrating keratoplasty.
Results
Based on the time interval between the first symptoms and the diagnosis of Acanthamoeba keratitis, it appeared that patients could be divided into two groups: an early treatment group (group I), consisting of six patients treated within 18 days of onset of symptoms, and a late treatment group (group II), composed of eight patients treated beyond that time. There were no statistically significant differences between the two groups as far as risk factors, clinical presentation, accuracy of diagnosis and method of diagnosis were concerned, although more extensive and deeper corneal involvement was noted in group II. Improvement in visual acuity following medical therapy was seen in all six patients in the early group and in three (37%) of the eight patients in the late group. One patient in group I needed urgent penetrating keratoplasty for corneal necrosis. In group II, two patients underwent penetrating keratoplasty à chaud to prevent corneal perforation and three patients needed penetrating keratoplasty to restore functional visual acuity.
Conclusion
A diagnostic delay of less than 18 days between onset of symptoms and start of anti-amoebic treatment results in a better final VA after medical treatment and obviates the need for urgent and elective penetrating keratoplasty.
Similar content being viewed by others
References
Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P (1993) Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 100:1238–1243
Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P (1993) A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992. Eye 7 (6):719–725
Bialasiewicz AA, Bischoff G, Walter A, Engelmann K, Richard G (2001) [Correlation of 55 samples of contact lens fluid and direct swabbings of the eye surface of symptomatic wearers of contact lenses]. Ophthalmologe 98:747–760
Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH (1995) Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology 102:1369–1373
Devonshire P, Munro FA, Abernethy C, Clark BJ (1993) Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol 77:41–45
Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, Tuft S (1997) Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104:1587–1592
Ficker LA, Kirkness C, Wright P (1993) Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 100:105–110
Illingworth CD, Cook SD (1996) Acanthamoeba keratitis. Surv Ophthalmol 42:493–508
Illingworth CD, Cook SD, Karabatsas CH, Easty DL (1995) Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 79:1078–1082
Jones DB, Visvesvara GS, Robinson NM (1975) Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K 95:221–232
Kremer I, Cohen EJ, Eagle RC, Udell I, Laibson PR (1994) Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 20:45–48
Larkin DF, Kilvington S, Easty DL (1990) Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 74:133–135
Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185–191
Lindquist TD (1998) Treatment of Acanthamoeba keratitis. Cornea 17:11–16
Mannis MJ, Tamaru R, Roth AM, Burns M, Thirkill C (1986) Acanthamoeba sclerokeratitis: determing diagnostic criteria. Arch Ophthalmol 104:1313–1317
Mathers WD, Sutphin JE, et al (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129–142
Moore MB, McCulley JP (1989) Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management. Br J Ophthalmol 73:271–275
Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD (1974) Amoebic infection of the eye. Lancet 2:1537–1540
Radford CF, Bacon AS, Dart JK, Minassian DC (1995) Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ 310:1567–1570
Radford CF, Minassian DC, Dart JK (2002) Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 86:536–542
Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10
Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M (1996) Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10 (4):413–421
Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108
Tabin G, Taylor H, Snibson G, Murchison A, Gushchin A, Rogers S (2001) Atypical presentation of Acanthamoeba keratitis. Cornea 20:757–759
Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69:778–782
Author information
Authors and Affiliations
Corresponding author
Additional information
Ilse Claerhout is a research assistant of the Flemish Fund for Scientific Research (FWO-Vlaanderen), Belgium
Rights and permissions
About this article
Cite this article
Claerhout, I., Goegebuer, A., Van Den Broecke, C. et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefe's Arch Clin Exp Ophthalmol 242, 648–653 (2004). https://doi.org/10.1007/s00417-003-0805-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-003-0805-7